Q3:15 Health Care M&A, by Spending

Last week we shared our data on health care M&A by sector in the third quarter of 2015. Here’s a look at the same sectors, by share of the dollars spent. If you’ve been following health care M&A at all, you won’t be surprised that the Managed Care sector (health insurers) accounts for about 50% of the $198 billion spent. That total, by the way, is also a new quarterly record. Look for The Health Care M&A Report, Third Quarter, for more in-depth analysis by sector. Read More »

Q3:15 Health Care M&A, By Sector

Health care M&A in the third quarter was quite robust, with 385 transations reported across 13 sectors. That’s a new record for any third quarter, by the way. We’ll have the full break-out in The Health Care M&A Report, Third Quarter 2015, due to be published by the end of this month. In the meantime, here’s how the sectors fared in Q3:15. Read More »

Signal Bay Buys Cannabis Testing Lab

The medical marijuana market has been growing like a weed, puns intended, but we haven’t logged many deals associated with it because they’re either undisclosed or simply too far afield to qualify. Last week, however, Las Vegas-based Signal Bay Inc. announced its acquisition of Bend, Oregon-based CannAlytical Research, a testing laboratory that is equipped with the latest high-performance liquid chromatography equipment. It provides state-mandated compliance tests for licensed medical marijuana dispensaries. Signal Bay, through its wholly owned subsidiaries Signal Bay Research, Inc. and Signal Bay Services, Inc., provides industry research, consulting, license application support and... Read More »

Two Deals for Renal Care Providers

Consolidation is still possible in the kidney-care sector, even though Fresenius Medical Care (NYSE: FMS) and DaVita HealthCare Partners (NYSE: DVA) appear to have about 90% of the U.S. market. Last week, DaVita announced its $415 million acquisition of Renal Ventures Management, LLC, a network of 36 dialysis clinics in six states, with headquarters in Lakewood, Colorado. RVM’s two physician divisions, Multispecialty Physician Partners and Physician Venture Partners were part of the deal. The second acquisition came from a much smaller player, privately held U.S. Renal Care, Inc. of Plano, Texas. The target was DSI Renal, owned by Frazier Healthcare and New Enterprise Associates, which... Read More »

Labs, MRI and Dialysis M&A

The Laboratories, MRI & Dialysis sector has been plagued by low reimbursement rates and competition from local hospitals for some time now, but you can’t really tell that to see the number of deals we’ve recorded in the last five years. Although the sector peaked with 47 deals announced in 2012, there have been 24 transactions made public this year (six of those in August), for a total of $2.3 billion. With CMS’s push to value-based and bundled payments, we expect to see more activity in this sector. Even though rates are low, there’s little uncertainty about them. YearSector dealsSector spending 201433$11.0 billion 201337$1.9 billion 201247$2.2 billion 201131$6.0 billion 201042$2.3... Read More »

Deal Volume Rose in July

July’s combined transaction total hit 127 deals, up 2% compared with the bang-up month of July 2014, which had 124 transactions. The Services sector had a strong performance, accounting for 60% of deal volume. Long-Term Care made up 27% of the volume overall with 34 announced transactions. That equalled the record set last July for the sector, and will probably break it as more deals come to light. The Managed Care sector posted some extra activity, although seven deals versus two deals the month prior and a year ago isn’t moving  the needle very high. July 2015 DealsShare of Total Services Behavioral Health Care32% Home Health & Hospice23% Hospitals76% Labs, MRI & Dialysis43%... Read More »